Literature DB >> 16931510

Muscle Na+ channelopathies: MRI detects intracellular 23Na accumulation during episodic weakness.

M-A Weber1, S Nielles-Vallespin, M Essig, K Jurkat-Rott, H-U Kauczor, F Lehmann-Horn.   

Abstract

BACKGROUND: Muscle channelopathies such as paramyotonia, hyperkalemic periodic paralysis, and potassium-aggravated myotonia are caused by gain-of-function Na+ channel mutations.
METHODS:
Methods: Implementation of a three-dimensional radial 23Na magnetic resonance (MR) sequence with ultra-short echo times allowed the authors to quantify changes in the total muscular 23Na signal intensity. By this technique and T2-weighted 1H MRI, the authors studied whether the affected muscles take up Na+ and water during episodes of myotonic stiffness or of cold- or exercise-induced weakness.
RESULTS: A 22% increase in the 23Na signal intensity and edema-like changes on T2-weighted 1H MR images were associated with cold-induced weakness in all 10 paramyotonia patients; signal increase and weakness disappeared within 1 day. A 10% increase in 23Na, but no increase in the T2-weighted 1H signal, occurred during cold- or exercise-induced weakness in seven hyperkalemic periodic paralysis patients, and no MR changes were observed in controls or exercise-induced stiffness in six potassium-aggravated myotonia patients. Measurements on native muscle fibers revealed provocation-induced, intracellular Na+ accumulation and membrane depolarization by -41 mV for paramyotonia, by -30 mV for hyperkalemic periodic paralysis, and by -20 mV for potassium-aggravated myotonia. The combined in vivo and in vitro approach showed a close correlation between the increase in 23Na MR signal intensity and the membrane depolarization (r = 0.92).
CONCLUSIONS: The increase in the total 23Na signal intensity reflects intracellular changes, the cold-induced Na+ shifts are greatest and osmotically relevant in paramyotonia patients, and even osmotically irrelevant Na+ shifts can be detected by the implemented 23Na MR technique.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16931510     DOI: 10.1212/01.wnl.0000233841.75824.0f

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

Review 1.  Diagnostics and therapy of muscle channelopathies--Guidelines of the Ulm Muscle Centre.

Authors:  F Lehmann-Horn; K Jurkat-Rott; R Rüdel
Journal:  Acta Myol       Date:  2008-12

2.  [Muscle channelopathies. Myotonias and periodic paralyses].

Authors:  K Jurkat-Rott; H Lerche; F Lehmann-Horn
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

Review 3.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

4.  Permanent muscular sodium overload and persistent muscle edema in Duchenne muscular dystrophy: a possible contributor of progressive muscle degeneration.

Authors:  M-A Weber; A M Nagel; M B Wolf; K Jurkat-Rott; H-U Kauczor; W Semmler; F Lehmann-Horn
Journal:  J Neurol       Date:  2012-04-28       Impact factor: 4.849

Review 5.  Paroxysmal muscle weakness: the familial periodic paralyses.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  J Neurol       Date:  2006-11-30       Impact factor: 4.849

6.  Gating pore currents in DIIS4 mutations of NaV1.4 associated with periodic paralysis: saturation of ion flux and implications for disease pathogenesis.

Authors:  Arie F Struyk; Vladislav S Markin; David Francis; Stephen C Cannon
Journal:  J Gen Physiol       Date:  2008-10       Impact factor: 4.086

Review 7.  Sodium channelopathies of skeletal muscle result from gain or loss of function.

Authors:  Karin Jurkat-Rott; Boris Holzherr; Michael Fauler; Frank Lehmann-Horn
Journal:  Pflugers Arch       Date:  2010-03-17       Impact factor: 3.657

Review 8.  Skeletal muscle channelopathies: new insights into the periodic paralyses and nondystrophic myotonias.

Authors:  Daniel Platt; Robert Griggs
Journal:  Curr Opin Neurol       Date:  2009-10       Impact factor: 5.710

Review 9.  Genotype-phenotype correlation and therapeutic rationale in hyperkalemic periodic paralysis.

Authors:  Karin Jurkat-Rott; Frank Lehmann-Horn
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

10.  Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness.

Authors:  Lawrence J Hayward; Joanna S Kim; Ming-Yang Lee; Hongru Zhou; Ji W Kim; Kumudini Misra; Mohammad Salajegheh; Fen-fen Wu; Chie Matsuda; Valerie Reid; Didier Cros; Eric P Hoffman; Jean-Marc Renaud; Stephen C Cannon; Robert H Brown
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.